Long-acting technologies
40 articles
Perspectives of People with HCV Lived Experience and Healthcare Providers on Potential Long-Acting Therapies
TAG releases an advocacy brief discussing findings from two surveys conducted among end users and healthcare providers/policy makers to understand their perspectives on potential long-acting therapies for HCV cure. More
LAT CAB: Two New Members
The LAT CAB added two new members: Giten Khwairakpam, from Thailand, and Bakyt Myrzaliev, from Kyrgyzstan. More
Long-Acting Therapies Trials Tracker for Hepatitis C, Opioid Use and Overdose Prevention Therapy, and Malaria
Treatment Action Group releases a trials tracker providing a compilation of ongoing and recently completed clinical trials on long-acting therapies for HCV, opioid use and overdose prevention therapy, and malaria in the R&D pipeline. More
International Workshop on Long Acting Anti-Infectives 2026
The 2nd International Workshop on Long Acting Anti-Infectives (LAAI) will take place in Philadelphia, USA and virtually from 20 to 21 May 2026. More
Long-Acting Therapies Trials Tracker for Malaria, Hepatitis C Virus, and Opioid Use and Overdose Prevention
Treatment Action Group releases a trials tracker providing a compilation of ongoing clinical trials on long-acting therapies for HCV, malaria, and opioid use and overdose prevention therapy in the R&D pipeline. More
